体外式膜型人工肺（Ecmo）システムの世界市場予測（2019年～2028年）

世界の体外式膜型人工肺（Ecmo）システム市場は、予測期間（2019年～2028年）の間に4.74％のCAGRで成長する見通しです。慢性疾患の負担の増加、ECMO技術の使用増加、技術の進歩により、同市場の成長が促進されています。Genitage ABのCardioHelpシステムはEMCOシステムの一つです。その特徴は、コンパクト、軽量、そして携帯性であり、主に呼吸器および心筋不全の場合に使用され、心臓と肺の両方をサポートします。このような技術の進歩は、同市場の成長に貢献すると予測されています。ただし、専門的な専門知識の不足とECMOシステムに関連する費用は、市場成長の妨げとなっています。

当レポートは、世界の体外式膜型人工肺（Ecmo）システム市場について調査しており、市場の成長および抑制要因、COVID-19の影響、モダリティ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査範囲と調査手法

• 調査目的
• 調査範囲
• 調査手法
• 前提条件と制限

第2章 エグゼクティブサマリー

• 市場規模・推計
• 市場概要

第3章 市場力学

• 市場の定義
• 主な成長要因
  • ECMO技術の使用増加
  • 技術の進歩
  • 慢性疾患の重篤化
• 主な抑制要因
  • 専門分野の不足
  • ECMOシステムの高いコスト
  • ECMOシステムに関連する副作用
  • 従来技術の存在

第4章 主要な分析

• ポーターのファイブフォース分析
• ECMOシステム市場に対するCOVID-19の影響
• 市場機会マトリクス
• ベンダー情勢
• 主な投資洞察

第5章 市場分析：モダリティ別

• VENO-VENOUS
• VENO-ARTERIAL
• その他

第6章 市場分析：用途別

• 呼吸器
• 心臓
• 体外心肺蘇生法（ECPR）

第7章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • ロシア
  • ベルギー
  • ポーランド
  • その他
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • オーストラリア・ニュージーランド
  • 韓国
  • タイ
  • インドネシア
  • ベトナム
  • その他
• その他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

• ABBOTT LABORATORIES
• ALUNG TECHNOLOGIES INC
• ELSIUS BIOMEDICAL INC
• EUROSETS
• GETINGE AB
• LIVANOVA PLC
• MEDTRONIC PLC
• MICROPORT SCIENTIFIC CORPORATION
• ニプロ株式会社
• ORIGEN BIOMEDICAL INC
• SPECTRUM MEDICAL
• テルモ株式会社
• XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

• TABLE 1: MARKET SNAPSHOT - EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM
• TABLE 2: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 3: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 4: GLOBAL VENO-VENOUS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 5: GLOBAL VENO-VENOUS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 6: GLOBAL VENO-ARTERIAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 7: GLOBAL VENO-ARTERIAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 8: GLOBAL OTHER MODALITIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 9: GLOBAL OTHER MODALITIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 10: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 11: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 12: GLOBAL RESPIRATORY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 13: GLOBAL RESPIRATORY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 14: GLOBAL CARDIAC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 15: GLOBAL CARDIAC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 16: GLOBAL EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 17: GLOBAL EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 18: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 19: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION MARKET, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 20: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 21: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 22: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 23: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 24: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 25: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
• TABLE 26: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
• TABLE 27: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

• FIGURE 1: LIST OF CHRONIC DISEASES
• FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
• FIGURE 3: OPPORTUNITY MATRIX
• FIGURE 4: VENDOR LANDSCAPE
• FIGURE 5: KEY INVESTMENT INSIGHTS
• FIGURE 6: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019
• FIGURE 7: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)
• FIGURE 8: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)
• FIGURE 9: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)
• FIGURE 10: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019
• FIGURE 11: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)
• FIGURE 12: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)
• FIGURE 13: GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)
• FIGURE 14: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
• FIGURE 15: THE UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 16: CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 17: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
• FIGURE 18: THE UNITED KINGDOM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 19: GERMANY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 20: FRANCE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 21: ITALY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 22: RUSSIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 23: BELGIUM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 24: POLAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 25: REST OF EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 26: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
• FIGURE 27: CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 28: JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 29: INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 30: AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 31: SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 32: THAILAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 33: INDONESIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 34: VIETNAM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 35: REST OF ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 36: REST OF WORLD EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
• FIGURE 37: LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
• FIGURE 38: MIDDLE EAST & AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

KEY FINDINGS

The global extra corporeal membrane oxygenation (ECMO) system market is projected to record a CAGR of 4.74% during the forecast period, 2019-2028. The rising burden of chronic disorders, growing usage of ECMO technology, and technological advancements, are set to propel the growth of the market.

MARKET INSIGHTS

The ECMO is used for critically ill patients and neonates. It is popular for providing life support for longer durations. The advent of new technologies is increasing the applications of ECMO technology. This includes enabling it for inter- and intra-hospital transport. Short-term and long-term applications have undergone considerable technological advancements. Modern ECMO technology has improved biocompatibility and portability, and offers a simple and safe way of provision.

The CardioHelp System by Genitage AB is an EMCO system. Its features are compact, light-weight, and portability. It supports both the heart and lungs. It is primarily used in the cases of respiratory and myocardial failure, and has a lifespan of almost 30 days. Such advancements in technologies are projected to contribute to the growth of the market. However, the lack of specialized expertise and the expenses involved in the ECMO system, pose a hindrance to market growth.

REGIONAL INSIGHTS

The geographical segregation of the global extra corporeal membrane oxygenation (ECMO) system market includes the analysis of North America, Asia Pacific, Europe, and the rest of the world. North America is projected to dominate the global market by 2028. The rising number of cardiovascular disease cases is attributed to the enhanced prospects of the market.

COMPETITIVE INSIGHTS

The companies are prioritizing innovation to sustain the competitive environment. Some of the leading companies in the market include, Elsius Biomedical Inc, Livanova Plc, Getinge AB, Alung Technologies Inc, Eurosets, etc.

Our report offerings include:

• Explore key findings of the overall market

• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

• Market Segmentation cater to a thorough assessment of key segments with their market estimations

• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

• 1.1. STUDY OBJECTIVES
• 1.2. SCOPE OF STUDY
• 1.3. METHODOLOGY
• 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

• 2.1. MARKET SIZE & ESTIMATES
• 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

• 3.1. MARKET DEFINITION
• 3.2. KEY DRIVERS
  • 3.2.1. INCREASED USAGE OF ECMO TECHNOLOGY
  • 3.2.2. TECHNOLOGICAL ADVANCEMENT
  • 3.2.3. GROWING BURDEN OF CHRONIC DISORDERS
• 3.3. KEY RESTRAINTS
  • 3.3.1. LACK OF SPECIALIZED EXPERTISE
  • 3.3.2. HIGH COST OF ECMO SYSTEM
  • 3.3.3. SIDE EFFECTS RELATED TO THE ECMO SYSTEM
  • 3.3.4. PRESENCE OF CONVENTIONAL TECHNIQUES

4. KEY ANALYTICS

• 4.1. PORTER'S FIVE FORCE ANALYSIS
  • 4.1.1. THREAT OF NEW ENTRY
  • 4.1.2. THREAT OF SUBSTITUTION
  • 4.1.3. BUYER'S POWER
  • 4.1.4. SUPPLIER'S POWER
  • 4.1.5. COMPETITIVE RIVALRY
• 4.2. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
• 4.3. OPPORTUNITY MATRIX
• 4.4. VENDOR LANDSCAPE
• 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY MODALITY

• 5.1. VENO-VENOUS
• 5.2. VENO-ARTERIAL
• 5.3. OTHER MODALITIES

6. MARKET BY APPLICATION

• 6.1. RESPIRATORY
• 6.2. CARDIAC
• 6.3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

7. GEOGRAPHICAL ANALYSIS

• 7.1. NORTH AMERICA
  • 7.1.1. THE UNITED STATES
  • 7.1.2. CANADA
• 7.2. EUROPE
  • 7.2.1. THE UNITED KINGDOM
  • 7.2.2. GERMANY
  • 7.2.3. FRANCE
  • 7.2.4. ITALY
  • 7.2.5. RUSSIA
  • 7.2.6. BELGIUM
  • 7.2.7. POLAND
  • 7.2.8. REST OF EUROPE
• 7.3. ASIA PACIFIC
  • 7.3.1. CHINA
  • 7.3.2. JAPAN
  • 7.3.3. INDIA
  • 7.3.4. AUSTRALIA & NEW ZEALAND
  • 7.3.5. SOUTH KOREA
  • 7.3.6. THAILAND
  • 7.3.7. INDONESIA
  • 7.3.8. VIETNAM
  • 7.3.9. REST OF ASIA PACIFIC
• 7.4. REST OF WORLD
  • 7.4.1. LATIN AMERICA
  • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILES

• 8.1. ABBOTT LABORATORIES
• 8.2. ALUNG TECHNOLOGIES INC
• 8.3. ELSIUS BIOMEDICAL INC
• 8.4. EUROSETS
• 8.5. GETINGE AB
• 8.6. LIVANOVA PLC
• 8.7. MEDTRONIC PLC
• 8.8. MICROPORT SCIENTIFIC CORPORATION
• 8.9. NIPRO CORPORATION
• 8.10. ORIGEN BIOMEDICAL INC
• 8.11. SPECTRUM MEDICAL
• 8.12. TERUMO MEDICAL CORPORATION
• 8.13. XENIOS AG (FRESENIUS SE & CO KGAA)